160. Congenital ichthyosis Clinical trials / Disease details
Clinical trials : 42 / Drugs : 71 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00208026 (ClinicalTrials.gov) | September 2005 | 13/9/2005 | Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome | Exploratory Safety and Systemic Absorption of Elidel (Pimecrolimus) 1% Cream for the Treatment of Netherton Syndrome | Netherton Syndrome | Drug: Pimecrolimus 1% Cream | Children's Hospital of Philadelphia | Novartis Pharmaceuticals | Completed | 2 Years | 18 Years | All | 3 | Phase 1/Phase 2 | United States |